midazolam has been researched along with pyrazolanthrone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Iida, H; Kozawa, O; Tanabe, K | 1 |
2 other study(ies) available for midazolam and pyrazolanthrone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Midazolam suppresses interleukin-1β-induced interleukin-6 release from rat glial cells.
Topics: Animals; Anthracenes; Cells, Cultured; Coumarins; Enzyme Inhibitors; Flavonoids; GABA Modulators; Humans; Hypnotics and Sedatives; Interleukin-1beta; Interleukin-6; Midazolam; Mitogen-Activated Protein Kinases; Neuroglia; Propofol; Rats; STAT3 Transcription Factor | 2011 |